2352-5789

Gynecologic Oncology Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 2176 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact2176 DOIs
2

Attach ORCID iDs across 1480 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1480 DOIs
3

Deposit reference lists for 348 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact348 DOIs

DOIs for this ISSN

Showing the top 5 of 2176 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cervical cancer screening and treatment in Uganda (10.1016/j.gore.2017.01.009)
Abstract ORCID
106.68 135
2 A scoping review: Facilitators and barriers of cervical canc… (10.1016/j.gore.2020.100605)
Abstract ORCID
91.94 68
3 BRCA mutation in high grade epithelial ovarian cancers (10.1016/j.gore.2019.07.007)
Abstract ORCID
88.91 59
4 FGFR3–TACC3: A novel gene fusion in cervical cancer (10.1016/j.gore.2015.06.005)
Abstract ORCID
88.54 58
5 Checkpoint inhibitors in ovarian cancer: A review of preclin… (10.1016/j.gore.2019.06.003)
Abstract ORCID
88.17 57
6 Paget's disease of the vulva: A review of 89 cases (10.1016/j.gore.2016.12.010)
Abstract ORCID
87.41 55
7 Myocarditis with tremelimumab plus durvalumab combination th… (10.1016/j.gore.2018.05.014)
Abstract ORCID
85.80 51
8 Topical therapies for the treatment of cervical intraepithel… (10.1016/j.gore.2020.100608)
Abstract ORCID
85.38 50
9 Combined immunotherapy and radiation for treatment of mucosa… (10.1016/j.gore.2016.04.001)
Abstract ORCID
84.95 49
10 A recurrent endometrial stromal sarcoma harbors the novel fu… (10.1016/j.gore.2017.03.002)
Abstract ORCID
84.95 49
11 Cervical cancer in Tanzania: A systematic review of current… (10.1016/j.gore.2019.05.008)
Abstract ORCID
84.95 49
12 Clinical trials in low and middle-income countries — Success… (10.1016/j.gore.2016.11.007)
Abstract ORCID
84.51 48
13 Malignant Brenner tumor of the ovary: Review and case report (10.1016/j.gore.2017.07.001)
Abstract ORCID
82.66 44
14 Staging surgery in early-stage ovarian mucinous tumors accor… (10.1016/j.gore.2017.08.006)
Abstract ORCID
82.17 43
15 Geographic disparities in the distribution of the U.S. gynec… (10.1016/j.gore.2017.11.006)
Abstract ORCID
81.67 42
16 A case of severe encephalitis while on PD-1 immunotherapy fo… (10.1016/j.gore.2018.03.007)
Abstract ORCID
80.64 40
17 Public health concern-driven insights and response of low- a… (10.1016/j.gore.2024.101460)
Abstract ORCID
80.64 40
18 Response to MEK inhibitor in small cell neuroendocrine carci… (10.1016/j.gore.2014.09.003)
Abstract ORCID
80.10 39
19 Resilience, hope and flourishing are inversely associated wi… (10.1016/j.gore.2018.06.002)
Abstract ORCID
78.41 36
20 Preparedness of Ob/Gyn residents for fellowship training in… (10.1016/j.gore.2015.03.004)
Abstract ORCID
77.82 35
21 Retreatment with carboplatin and paclitaxel for recurrent en… (10.1016/j.gore.2019.04.002)
Abstract ORCID
77.82 35
22 A quality improvement pathway to rapidly increase telemedici… (10.1016/j.gore.2021.100708)
Abstract ORCID
77.20 34
23 Prophylactic oophorectomy for hereditary small cell carcinom… (10.1016/j.gore.2015.02.002)
Abstract ORCID
75.26 31
24 Mesonephric-like adenocarcinoma of the ovary with co-existen… (10.1016/j.gore.2020.100657)
Abstract ORCID
75.26 31
25 Uterine mesenchymal tumors harboring ALK fusions and respons… (10.1016/j.gore.2021.100852)
Abstract ORCID
75.26 31
26 Treatment and follow-up of malignant struma ovarii: Regardin… (10.1016/j.gore.2016.05.014)
Abstract ORCID
74.57 30
27 Cervical cancer in women over 65: An analysis of screening (10.1016/j.gore.2018.05.010)
Abstract ORCID
73.86 29
28 Molecular profiling of mesonephric and mesonephric-like carc… (10.1016/j.gore.2020.100652)
Abstract ORCID
73.86 29
29 Successful treatment of metastatic refractory gestational ch… (10.1016/j.gore.2020.100625)
Abstract ORCID
73.12 28
30 BRCA1 reversion mutation acquired after treatment identified… (10.1016/j.gore.2017.06.010)
Abstract ORCID
72.36 27
31 Almost half of women with endometrial cancer or hyperplasia… (10.1016/j.gore.2015.07.002)
Abstract ORCID
71.57 26
32 A case of multi-agent drug resistant choriocarcinoma treated… (10.1016/j.gore.2020.100574)
Abstract ORCID
71.57 26
33 Perivascular epithelioid cell tumors (PEComa) of the female… (10.1016/j.gore.2020.100603)
Abstract ORCID
71.57 26
34 Predicted neoantigen load in non-hypermutated endometrial ca… (10.1016/j.gore.2016.12.009)
Abstract ORCID
70.75 25
35 Endometrioid adenocarcinoma arising from deep infiltrating e… (10.1016/j.gore.2015.07.003)
Abstract ORCID
69.90 24
36 Robotically assisted delayed total laparoscopic hysterectomy… (10.1016/j.gore.2016.05.009)
Abstract ORCID
69.90 24
37 Case report: NTRK1-rearranged cervical sarcoma with fibrosar… (10.1016/j.gore.2021.100845)
Abstract ORCID
69.90 24
38 Increased disparities associated with black women and abnorm… (10.1016/j.gore.2022.101041)
Abstract ORCID
69.90 24
39 Paraneoplastic antigens as biomarkers for early diagnosis of… (10.1016/j.gore.2017.06.006)
Abstract ORCID
69.01 23
40 The “hook effect” causing a negative pregnancy test in a pat… (10.1016/j.gore.2017.06.008)
Abstract ORCID
69.01 23
41 Binimetinib (MEK162) in recurrent low-grade serous ovarian c… (10.1016/j.gore.2018.05.011)
Abstract ORCID
69.01 23
42 Patients’ self-reported factors influencing cervical cancer… (10.1016/j.gore.2020.100596)
Abstract ORCID
69.01 23
43 A prospective pilot study on the incidence of post-operative… (10.1016/j.gore.2015.12.002)
Abstract ORCID
68.09 22
44 Primary signet ring cell adenocarcinoma of the uterine cervi… (10.1016/j.gore.2016.01.004)
Abstract ORCID
68.09 22
45 Elevated tumor mutational burden and prolonged clinical resp… (10.1016/j.gore.2017.06.013)
Abstract ORCID
68.09 22
46 The use of QuikClot combat gauze in cervical and vaginal hem… (10.1016/j.gore.2017.07.012)
Abstract ORCID
68.09 22
47 Results of an abbreviated Phase Ib study of the HDAC6 inhibi… (10.1016/j.gore.2019.07.010)
Abstract ORCID
68.09 22
48 Non-prescription cannabis use for symptom management amongst… (10.1016/j.gore.2019.100497)
Abstract ORCID
68.09 22
49 Beneficial effects of exercise on chemotherapy-induced perip… (10.1016/j.gore.2022.100927)
Abstract ORCID
68.09 22
50 In-vitro maturation and cryopreservation of oocytes at the t… (10.1016/j.gore.2015.07.007)
Abstract ORCID
67.12 21